Isodifa

Isotretinoin, the active ingredient in Isodifa, is a retinoid presented as an oral formulation for systemic use. It is prescribed for severe recalcitrant nodular acne and severe acne vulgaris in patients who have not responded to conventional therapies.

GNH USA supplies Isodifa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable sourcing for healthcare providers across global markets. All batches are manufactured under GMP conditions and undergo rigorous quality testing before distribution.

Isodifa (isotretinoin) is used in dermatology to treat severe forms of acne.

- Severe recalcitrant nodular acne: reduces inflammatory lesions and prevents new nodule formation. - Severe acne vulgaris: decreases comedones, papules and pustules, leading to clearer skin. - Acne with high scarring risk: minimizes long‑term scar development.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Xerosis (dryness of eyes and nose). - Photosensitivity. - Headache. - Arthralgia or muscle aches.

Serious or Rare Side Effects: - Severe depression or suicidal thoughts. - Inflammatory bowel disease. - Elevated liver enzymes or hepatic dysfunction. - Hypertriglyceridemia. - Pseudotumor cerebri (increased intracranial pressure). - Teratogenic effects leading to birth defects.

Isodifa requires careful monitoring and specific safety measures.

- Pregnancy contraindication: avoid use in women who are pregnant or may become pregnant. - Contraception: employ effective birth control methods throughout treatment and for one month after discontinuation. - Laboratory monitoring: check liver function and lipid levels before and during therapy. - Vitamin A intake: do not use additional vitamin A supplements or retinoid‑containing products. - Sun exposure: limit UV exposure and use sunscreen to reduce photosensitivity. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Isotretinoin may interact with several medicines, requiring dose adjustments or monitoring.

Major Interactions (Avoid): - Tetracycline antibiotics: antagonistic effect reducing efficacy of both agents. - Vitamin A supplements or other retinoids: increased risk of toxicity. - Phenobarbital and other enzyme inducers: may lower isotretinoin plasma concentrations.

Moderate Interactions (Monitor Closely): - Oral contraceptives: isotretinoin may reduce contraceptive effectiveness; additional barrier methods are advised. - Anticoagulants (e.g., warfarin): potential alteration of INR; monitor coagulation parameters. - Other lipid‑altering drugs: may exacerbate hypertriglyceridemia; check lipid profile regularly.